Pricing Log in Create free account
Friday 6 November 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

BIO Healthcare Medical Devices

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue
+0.52%
EPS
+234.9%
Free cash flow
+8.07%
Total debt
+0.11%

Quarter to September 2026, against a year earlier

380.81 11.81 +3.20%
Market cap
$9.9B
P/E
9.7×
Fwd P/E
44.7×
Dividend yield
—
F-score
5/9
Altman Z
3.20
Beneish M
−2.29
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bio-Rad Laboratories, Inc. (BIO) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Bio-Rad Laboratories, Inc. (BIO) trades at a EV/Sales of 3.7×. Over the past ten years it has ranged from 1.4× (January 2015) to 8.1× (September 2021); the current reading is higher than 58% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.1× (10.61%)
FY2024 3.4× (0.03%)
FY2023 3.4× (19.75%)
FY2022 4.3× (42.34%)
FY2021 7.4× 15.33%
FY2020 6.4× 43.46%
FY2019 4.5× 57.46%
FY2018 2.8× (10.01%)
FY2017 3.2× 31.50%
FY2016 2.4× 31.63%

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.7× 30.25%
Jun 2026 2.9× 4.00%
Mar 2026 2.8× (9.94%)
Dec 2025 3.1× 6.96%
43 more quarters

Against its own ten years

Low 1.4× High 8.1×
Ten-year median 3.5×
Current reading's percentile 54

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.6×
BRKR Bruker Corporation compare 3.0×
PODD Insulet Corporation compare 3.5×
GMED Globus Medical, Inc. compare 3.5×
BIO Bio-Rad Laboratories, Inc. 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
PEN Penumbra, Inc. compare 7.7×
TXG 10x Genomics compare 11.5×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BIO